Strs Ohio Intellia Therapeutics, Inc. Transaction History

Strs Ohio

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$23.16 - $32.34 $136,644 - $190,806	-5,900 Reduced 85.51%	1,000 $30,000
Q2 2023 Jul 31, 2023	BUY	$34.58 - $46.03 $51,870 - $69,045	1,500 Added 27.78%	6,900 $281,000
Q1 2023 Aug 02, 2023	SELL	$33.3 - $44.82 $49,949 - $67,230	-1,500 Reduced 21.74%	5,400 $201,000
Q1 2023 Apr 27, 2023	SELL	$33.3 - $44.82 $273,060 - $367,524	-8,200 Reduced 60.29%	5,400 $201,000
Q4 2022 Jan 26, 2023	SELL	$33.21 - $62.69 $76,383 - $144,187	-2,300 Reduced 14.47%	13,600 $474,000
Q2 2022 Jul 25, 2022	BUY	$38.49 - $76.21 $34,641 - $68,589	900 Added 6.0%	15,900 $822,000
Q1 2022 Apr 21, 2022	SELL	$58.27 - $118.99 $34,962 - $71,394	-600 Reduced 3.85%	15,000 $1.09 Million
Q4 2021 Jan 24, 2022	SELL	$100.76 - $138.36 $141,064 - $193,704	-1,400 Reduced 8.24%	15,600 $1.84 Million
Q3 2021 Oct 22, 2021	BUY	$132.37 - $176.78 $92,659 - $123,746	700 Added 4.29%	17,000 $2.28 Million
Q2 2021 Jul 26, 2021	BUY	$60.88 - $161.91 $182,640 - $485,730	3,000 Added 22.56%	16,300 $2.64 Million
Q1 2021 Apr 23, 2021	BUY	$46.59 - $83.68 $111,816 - $200,832	2,400 Added 22.02%	13,300 $1.07 Million
Q4 2020 Jan 25, 2021	BUY	$18.83 - $63.53 $205,246 - $692,477	10,900 New	10,900 $592,000

336

96.1M

1.06M

863K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $707M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.